Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

[Updated roles of adrenergic receptors in prostate cancer].

Luo HQ, Kuang XX, Li BY.

Zhonghua Nan Ke Xue. 2014 Apr;20(4):372-6. Chinese.

PMID:
24873168
[PubMed - in process]
2.

Neuroendocrine pathogenesis in adenocarcinoma of the prostate.

Hansson J, Abrahamsson PA.

Ann Oncol. 2001;12 Suppl 2:S145-52. Review.

PMID:
11762343
[PubMed - indexed for MEDLINE]
3.

Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.

Cuellar DC, Rhee J, Kyprianou N.

Anticancer Res. 2002 May-Jun;22(3):1673-9.

PMID:
12168853
[PubMed - indexed for MEDLINE]
4.

Targeting Gbetagamma signaling to inhibit prostate tumor formation and growth.

Bookout AL, Finney AE, Guo R, Peppel K, Koch WJ, Daaka Y.

J Biol Chem. 2003 Sep 26;278(39):37569-73. Epub 2003 Jul 17.

PMID:
12869546
[PubMed - indexed for MEDLINE]
Free Article
5.

Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.

Alberti C.

G Chir. 2010 Nov-Dec;31(11-12):568-74.

PMID:
21232206
[PubMed - indexed for MEDLINE]
6.

Androgen receptor is a tumor suppressor and proliferator in prostate cancer.

Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, Messing EM, Yao J, Yeh S, Chang C.

Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12182-7. doi: 10.1073/pnas.0804700105. Epub 2008 Aug 22.

PMID:
18723679
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation.

Siddiqui EJ, Shabbir M, Mikhailidis DP, Thompson CS, Mumtaz FH.

J Urol. 2006 Oct;176(4 Pt 1):1648-53.

PMID:
16952708
[PubMed - indexed for MEDLINE]
8.

Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.

Murthy S, Agoulnik IU, Weigel NL.

Prostate. 2005 Sep 1;64(4):362-72.

PMID:
15754350
[PubMed - indexed for MEDLINE]
9.

Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.

Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Taskén KA.

Prostate. 2008 Jul 1;68(10):1133-42. doi: 10.1002/pros.20778.

PMID:
18454446
[PubMed - indexed for MEDLINE]
10.

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M.

Adv Enzyme Regul. 2006;46:249-79. Epub 2006 Jul 18.

PMID:
16854453
[PubMed - indexed for MEDLINE]
11.

Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth.

Mashima T, Okabe S, Seimiya H.

Mol Pharmacol. 2010 Nov;78(5):846-54. doi: 10.1124/mol.110.064790. Epub 2010 Aug 13.

PMID:
20709811
[PubMed - indexed for MEDLINE]
Free Article
12.

Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.

Ozkan EE.

Mol Cell Endocrinol. 2011 Sep 15;344(1-2):1-24. doi: 10.1016/j.mce.2011.07.002. Epub 2011 Jul 18. Review.

PMID:
21782884
[PubMed - indexed for MEDLINE]
13.

Guanosine phosphate binding protein coupled receptors in prostate cancer: a review.

Raj GV, Barki-Harrington L, Kue PF, Daaka Y.

J Urol. 2002 Mar;167(3):1458-63. Review.

PMID:
11832770
[PubMed - indexed for MEDLINE]
14.

Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells.

Zhang Y, Ni J, Messing EM, Chang E, Yang CR, Yeh S.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7408-13.

PMID:
12032296
[PubMed - indexed for MEDLINE]
Free PMC Article
15.
16.

G protein-coupled receptors provide survival signals in prostate cancer.

Yowell CW, Daaka Y.

Clin Prostate Cancer. 2002 Dec;1(3):177-81. Review.

PMID:
15046693
[PubMed - indexed for MEDLINE]
17.

Quinazoline-based alpha 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-beta signalling and I kappa B alpha induction.

Partin JV, Anglin IE, Kyprianou N.

Br J Cancer. 2003 May 19;88(10):1615-21.

PMID:
12771931
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells.

Ye L, Lewis-Russell JM, Davies G, Sanders AJ, Kynaston H, Jiang WG.

Int J Oncol. 2007 Feb;30(2):521-9.

PMID:
17203235
[PubMed - indexed for MEDLINE]
19.
20.

β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1.

Zhang D, Ma QY, Hu HT, Zhang M.

Cancer Biol Ther. 2010 Jul 1;10(1):19-29.

PMID:
20424515
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk